Qatar Investment Authority
Qatar Investment Authority is a sovereign wealth fund that protects and grows Qatar’s financial assets and to diversify the economy.
Business Model:
Revenue: $2.9M
Employees: 201-500
Rankings
Detailed Qatar Investment Authority Information
Geographic Data
Address: Q-tel tower, Diplomatic Street
City: Doha
State: other
Zip:
Country: QA
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Facebook
Linkedin
Crunchbase
Metrics
2,873,619Website Global Rank
5,149Website Monthly Traffic
Twitter Followers
Description
The QIA was founded by the State of Qatar in 2005 to strengthen the country&s;s economy by diversifying into new asset classes. Building on the heritage of Qatar investments dating back more than three decades, its growing portfolio of long-term strategic investments helps complement the state&s;s huge wealth in natural resources. Qatar&s;s goal is to become a major international center for finance and investment management, a vision shared by its government, people, and institutions. Headquartered in Doha, the QIA is structured to operate at the very highest levels of global investing. As a world-class investor, the QIA adheres to the strictest financial and commercial disciplines. It has a strong track record of investing in different asset classes, including listed securities, property, alternative assets, and private equity in all the major capital markets as well as the newer emerging markets.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2021 | Pepgen | Venture Round | 0 |
| 1/2022 | Carsome | Series E | 0 |
| 4/2021 | Swiggy | Series J | 0 |
| 6/2023 | Isotopen Technologien München | Private Equity Round | 0 |
| 8/2021 | VerSe Innovation | Series I | 451M |
| 4/2019 | Super | Series B | 20M |
| 12/2020 | Fluence | Private Equity Round | 125M |
| 4/2022 | Starling Bank | Series D | 164.2M |
| 4/2022 | BioXcel Therapeutics | Post-IPO Equity | 5M |
| 12/2021 | Group One Holdings | Private Equity Round | 0 |
| 1/2022 | Swiggy | Series J | - |
| 7/2021 | Flipkart | Pre-IPO | 3.6B |
| 3/2021 | Entrada Therapeutics | Series B | 0 |
| 3/2021 | Century Therapeutics | Series C | 0 |
| 1/2022 | Checkout.com | Series D | 0 |
| 7/2019 | BYJU’S | Venture Round | 0 |
| 1/2023 | Ensoma | Series B | 0 |
| 1/2020 | Califia Farms | Series D | 225M |
| 2/2021 | VerSe Innovation | Series H | 100M |
| 7/2021 | impact.com | Venture Round | 0 |
| 6/2021 | Age of Learning | Series C | 300M |
| 1/2021 | Tessera Therapeutics | Series B | 0 |
| 1/2022 | Swiggy | Venture Round | 0 |
| 7/2019 | Compass | Series G | 370M |
| 7/2020 | Traveloka | Venture Round | 250M |
| 8/2022 | Senda Biosciences | Series C | 123M |
| 3/2021 | Eat Just | Venture Round | 0 |
| 3/2022 | Fanatics | Private Equity Round | 1.5B |
| 3/2020 | Tandem | Venture Round | 78.4M |
| 7/2020 | CureVac | Venture Round | 126M |
| 8/2021 | T-knife | Series B | 110M |
| 12/2021 | Infarm | Series D | 0 |
| 12/2021 | Travelling Folks | Pre Seed Round | 30.7k |
| 6/2021 | Thumbtack | Series I | 275M |
| 11/2020 | Inigo | Private Equity Round | 0 |
| 2/2023 | Oricell Therapeutics | Series B | 0 |
| 1/2023 | The North Road Company | Private Equity Round | 0 |
| 10/2022 | THG | Post-IPO Secondary | 0 |
| 10/2022 | BYJU’S | Private Equity Round | 0 |
| 9/2022 | InnovaFeed | Series D | 0 |
| 8/2022 | JenaValve Technology | Series C | 0 |
| 2/2022 | Ventus Therapeutics | Series C | 0 |
| 7/2020 | Praxis Precision Medicines | Series C | 0 |
| 12/2014 | Flipkart | Series H | 700M |
| 9/2018 | Compass | Series F | 400M |
| 12/2022 | Snyk | Series G | 0 |
| 5/2023 | Builder.ai | Series D | 0 |
| 2/2011 | Fisker Automotive | Private Equity Round | 0 |
| 9/2008 | Fisker Automotive | Series C | 0 |
| 3/2021 | Starling Bank | Series D | 0 |
| 1/2019 | Airtel Africa | Funding Round | 200M |
| 12/2018 | Lu.com | Series C | 0 |
| 6/2023 | Carsome | Venture Round | - |
| 8/2020 | Xpeng Motors | Series C | 400M |
| 3/2021 | Siemens Healthineers | Post-IPO Equity | 2.8B |
| 3/2021 | OncoResponse | Series C | 0 |
| 8/2021 | QuantumScape | Post-IPO Equity | 446M |
| 5/2019 | SoFi | Venture Round | 500M |
| 1/2021 | Paycor | Private Equity Round | 0 |
| 4/2022 | BioXcel Therapeutics | Post-IPO Debt | 135M |
| 2/2022 | Insider | Series D | 0 |
| 5/2018 | D2iq | Series D | 125M |
| 8/2021 | Trendyol Group | Private Equity Round | 0 |
| 7/2021 | Airtel Mobile Commerce BV | Secondary Market | 200M |
| 2/2022 | Advanced Integration Technology | Secondary Market | - |
| 10/2021 | Rebel Foods | Series F | 175M |
| 6/2021 | Bright Peak Therapeutics | Series B | 107M |
| 8/2022 | Celonis | Series D | 0 |
| 3/2022 | Fanatics | Venture Round | 0 |
| 6/2020 | Zuoyebang | Series E | 0 |
| 12/2022 | SK on | Private Equity Round | 0 |
| 9/2018 | OncoResponse | Series B | 40M |
| 12/2021 | Space Perspective | Secondary Market | - |
| 11/2017 | Codiak Biosciences | Series C | 76.5M |
| 12/2014 | Uber | Series E | 1.2B |
| 5/2023 | Builder.ai | Series D | 0 |
| 2/2023 | Oricell Therapeutics | Series B | 0 |
| 1/2023 | The North Road Company | Private Equity Round | 0 |
| 1/2023 | Ensoma | Series B | 0 |
| 12/2022 | Snyk | Series G | 0 |
| 12/2022 | SK on | Private Equity Round | 0 |
| 10/2022 | THG | Post-IPO Secondary | 0 |
| 10/2022 | BYJU’S | Private Equity Round | 0 |
| 9/2022 | InnovaFeed | Series D | 0 |
| 8/2022 | JenaValve Technology | Series C | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
